Dr. Zaven Kaprielian

Science Advisor

Zaven is an award-winning professor who taught Neuroscience at the prestigious Albert Einstein College of Medicine. After initially studying Aerospace Engineering, Zaven went on to get his PhD in Biophysics from Johns Hopkins University and then studied Neuroscience for the next three decades - leading to over 35 peer-reviewed publications. Zaven has valuable experience in industry as Chief Science Officer of biotech companies like Remix, Ilius, and ENDLYZ Therapeutics. Aside from working with the team at Verse, Zaven runs his own Biotech consulting firm which focuses on neurodegeneration.